A Phase 2, Open-Label, Multicenter, Randomized Study to Evaluate the Pharmacokinetics and Safety of Twice Yearly Long-Acting Subcutaneous Lenacapavir for Pre-Exposure Prophylaxis in People Who Inject Drugs.
Need additional information?
Black or African American
Latino
White
API
American Indian or Alaska Native
Other
Male
Female
Transgender
Gender Non-binary
Facebook
Instagram/Twitter
Flyer
Dating App (Grindr, Growlr, Adam4Adam, etc.)
Online
Word-of-mouth